460 search results for “anti-cancer drug steen” in the Staff website
-
Charlie SteenFaculty of Governance and Global Affairs
-
Joesjka van der SteenUniversity Facility Services
-
Tamara van den Steen
Faculty of Science
-
Jeltje van der SteenASSC
-
Jasper van der SteenFaculty of Humanities
-
Tommy van SteenFaculty of Governance and Global Affairs
-
Bart van der SteenLeiden University Libraries
-
Student alcohol and drug abuse: what can staff do?
It’s vital that universities are able to recognise the signs of alcohol and drug misuse in students. Staff also have an important role to play in talking about substance use. ‘That one conversation can make a difference’, says Jitske Hoogervorst, an adviser at Brijder addiction treatment services.
-
Leiden researchers pioneer ‘green’ framework for sustainable drug development
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and Justin Lian have developed a framework to help the healthcare system assess the economic and environmental sustainability of medical compounds.
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investment
How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.
-
Hildert BronkhorstFaculty of Science
-
Peter BouwmanFaculty of Science
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
Giulia CallegaroFaculty of Science
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
-
Bob van de WaterFaculty of Science
-
Alexander KrosFaculty of Science
-
Gerard van WestenFaculty of Science
-
Laura HeitmanFaculty of Science
-
Meiling GaoFaculty of Science
-
Eline DekeysterFaculty of Social and Behavioural Sciences
-
Skin researcher calls for multidisciplinary collaboration: ‘I want to pool expertise’
In dermatology, there should be a high level of multidisciplinary collaboration among institutes and specialists, Professor of Translational Dermatology, Robert Rissmann, will say in his inaugural lecture on 8 July. He is building an infrastructure that will put pre-clinical and clinical skin research…
-
Madeline KavanaghFaculty of Science
-
Marije NiemeijerFaculty of Science
-
Bas ter BraakFaculty of Science
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
Mario van der SteltFaculty of Science
-
Margo DonaFaculty of Science
-
Laura de JongFaculty of Science
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases
RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the LUMC in the initiative.
-
Erik DanenFaculty of Science
-
Roxanne KieltykaFaculty of Science
-
Sebastian PomplunFaculty of Science
-
Coen van HasseltFaculty of Science
-
Anthe JanssenFaculty of Science
-
Serkan AslanFaculty of Science
-
ICT-contact persons
For each university unit, the ICT Shared Service Centre (ISSC) has an appointed ICT contact person responsible for applying for ICT facilities for research, teaching and operational management.
-
Thomas HankemeierFaculty of Science
-
Olivier BéquignonFaculty of Science
-
Vici grants for research into antibodies, galaxies and Indigenous communities
Three Leiden researchers have been awarded a Vici grant by the Dutch Research Council. The funding of up to 1.5 million euros supports ‘talented, adventurous and pioneering researchers’. A total of 39 projects at Dutch institutions will receive a grant.
-
Doctors discover a simple method to predict the risk of brain tumour recurrence
The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.
-
Daisy BatenburgFaculty of Science
-
Andraniek Evadgian
Faculty of Science
-
Kim ElbertseFaculty of Science
-
Elsa NeubertFaculty of Science
-
Irene Pascual GarciaFaculty of Science
-
Jasper DekkerFaculty of Humanities
-
Robyn CreminFaculty of Governance and Global Affairs
-
Jasmijn BoekenFaculty of Governance and Global Affairs
-
Rob van WijkFaculty of Science